Abbott Laboratories, US0028241000

Abbott Laboratories schedules third-quarter results for October 21; stock pre-market at EUR 91.62

Published on 10/14/2026 at 08:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott Laboratories is expected to report third-quarter results on October 21. The stock was at EUR 91.62 at Lang & Schwarz pre-market on October 14, 2026.

Results and dividend dates

  • Abbott is expected to report third-quarter results on October 21, 2026.
  • Abbott Laboratories stock was at EUR 91.62 at 8:28 a.m. CEST on October 14, 2026, at Lang & Schwarz.
  • A quarterly dividend of USD 0.63 has an October 15, 2026, ex-dividend date.
Flatlay Glukosesensor Stethoskop Aktien Abbott Laboratories US0028241000
Abbott Laboratories US0028241000 Flatlay generischer Glukose-Sensor Stethoskop Reagenzgläser Aktien-Zertifikat ISIN-Karte Marmor Tisch, Illustration mit AI erstellt.

Abbott Laboratories is expected to release its third-quarter 2026 results before the market opens on October 21, 2026, according to MarketBeat. Abbott Laboratories stock was at EUR 91.62 at Lang & Schwarz at 8:28 a.m. CEST on October 14, 2026.

Pre-market price

Lang & Schwarz showed Abbott Laboratories at EUR 91.62 in pre-market trading at 8:28 a.m. CEST on October 14, 2026. The bid was EUR 91.36 and the ask was EUR 91.88. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.

What matters today

MarketBeat reported that Abbott is expected to release its third-quarter results on October 21, 2026, before the market opens. The report said Rothschild & Co Redburn upgraded Abbott to a buy rating on October 2, 2026. Abbott's quarterly dividend is USD 0.63 per share, with an ex-dividend date of October 15, 2026, according to MarketBeat.

Market context: Market report S&P 500.

More news and analysis on Abbott Laboratories stock

Disclaimer...

en | US0028241000 | ABBOTT LABORATORIES | boerse | 70321445 | bgmi